Clinical Trial Update: Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating octreotide with tamoxifen and chemotherapy in women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED